Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-11 Sale | 2024-04-15 4:21 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 40,000 | $91.13 | $3,645,000 | 924,527 (Indirect Direct) | View |
2024-04-10 Sale | 2024-04-12 3:07 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 2,286 | $90 | $205,740 | 16,156 (Direct) | View |
2024-03-28 Sale | 2024-04-01 4:54 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 24,602 | $88.34 | $2,173,341 | 55,856 (Direct) | View |
2024-03-05 Sale | 2024-03-07 6:54 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 35,341 | $85.18 | $3,010,396 | 212,117 (Direct) | View |
2024-03-05 Sale | 2024-03-07 5:35 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 2,000 | $86.11 | $172,223 | 807,736 (Indirect Direct) | View |
2024-03-05 Sale | 2024-03-07 5:32 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 4,000 | $87.07 | $348,280 | 94,047 (Direct) | View |
2024-02-27 Sale | 2024-02-29 5:05 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 1,000 | $90.35 | $90,350 | 809,736 (Indirect Direct) | View |
2024-02-08 Sale | 2024-02-12 5:20 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 30,000 | $89.03 | $2,670,750 | 944,135 (Indirect Direct) | View |
2024-01-09 Sale | 2024-01-11 2:40 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 20,000 | $97.28 | $1,945,700 | 1,004,695 (Indirect Direct) | View |
2023-12-21 Sale | 2023-12-22 5:14 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 10,000 | $93.99 | $939,900 | 853,645 (Indirect Direct) | View |
2023-12-13 Sale | 2023-12-14 6:18 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 13,764 | $95.3 | $1,311,709 | 55,710 (Direct) | View |
2023-08-16 Sale | 2023-08-17 3:57 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 5,000 | $90 | $450,000 | 60,804 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-11 Exercise | 2024-04-15 4:21 pm | 2014-12-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 40,000 | $0 | 924,527 (Direct) | View |
2024-04-11 Exercise | 2024-04-15 4:21 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 40,000 | $63.1 | 924,527 (Direct) | View |
2024-03-18 Exercise | 2024-03-20 5:13 pm | 2014-07-19 2024-03-18 | BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director | 10,000 | $0 | 31,299 (Direct) | View |
2024-03-18 Exercise | 2024-03-20 5:13 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director | 10,000 | $79.7 | 31,299 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 5:13 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director | 9,510 | $83.81 | 31,299 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 8:55 pm | 2025-03-15 2034-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 11,770 | $0 | 25,492 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-19 8:55 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 372 | $83.87 | 25,492 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 8:53 pm | 2025-03-15 2034-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 33,250 | $0 | 103,448 (Direct) | View |
2024-03-15 Tax Withholding | 2024-03-19 8:53 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 21,699 | $83.87 | 103,448 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 8:50 pm | 2025-03-15 2034-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 34,180 | $0 | 101,957 (Direct) | View |
2024-03-15 Tax Withholding | 2024-03-19 8:50 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 20,424 | $83.87 | 101,957 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 8:48 pm | 2025-03-15 2034-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 36,940 | $0 | 97,399 (Direct) | View |
2024-03-15 Tax Withholding | 2024-03-19 8:48 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 20,789 | $83.87 | 97,399 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 8:46 pm | 2025-03-15 2034-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 59,100 | $0 | 237,732 (Direct) | View |
2024-03-15 Tax Withholding | 2024-03-19 8:46 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 33,485 | $83.87 | 237,732 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 8:42 pm | 2025-03-15 2034-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer | 76,830 | $0 | 192,201 (Direct) | View |
2024-03-15 Tax Withholding | 2024-03-19 8:40 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 85,209 | $83.87 | 722,527 (Direct) | View |
2024-03-15 Tax Withholding | 2024-03-19 8:36 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 22,580 | $83.87 | 71,467 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 5:18 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 35,125 | $0 | 81,248 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 5:16 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 36,187 | $0 | 91,897 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 5:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 36,187 | $0 | 88,201 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 5:12 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 37,243 | $0 | 98,047 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 5:10 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 53,204 | $0 | 247,458 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 5:05 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 143,601 | $0 | 809,736 (Direct) | View |
2024-02-08 Exercise | 2024-02-12 5:20 pm | 2014-12-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 30,000 | $0 | 944,135 (Direct) | View |
2024-02-08 Exercise | 2024-02-12 5:20 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 30,000 | $63.1 | 944,135 (Direct) | View |
2024-01-18 Acquisition | 2024-02-12 5:20 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 40 | $92.6 | 944,135 (Direct) | View |
Ownership | 2024-02-12 3:24 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 0 | $0 | 667,095 (Indirect) | View |
2023-02-06 Ownership | 2024-02-12 3:24 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 5,600 | $0 | 667,095 (Direct) | View |
2023-04-28 Ownership | 2024-02-12 3:04 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 318 | $66.88 | 46,123 (Direct) | View |
2024-01-08 Gift | 2024-01-23 7:47 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 3,000 | $0 | 112,547 (Direct) | View |
2024-01-09 Exercise | 2024-01-11 2:40 pm | 2014-12-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 20,000 | $0 | 1,004,695 (Direct) | View |
2024-01-09 Exercise | 2024-01-11 2:40 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 20,000 | $63.1 | 1,004,695 (Direct) | View |
2024-01-08 Acquisition | 2024-01-11 2:40 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 50 | $99.05 | 1,004,695 (Direct) | View |
2023-12-27 Option Award | 2023-12-28 1:18 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Bodem Barbara W. Director | 2,180 | $0 | 2,180 (Direct) | View |
2023-12-27 Option Award | 2023-12-28 1:13 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Enyedy Mark J Director | 2,180 | $0 | 2,180 (Direct) | View |
2023-12-27 Option Award | 2023-12-28 1:03 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director | 2,180 | $0 | 2,180 (Direct) | View |
2023-12-21 Exercise | 2023-12-22 5:14 pm | 2014-12-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 10,000 | $0 | 853,645 (Direct) | View |
2023-12-21 Exercise | 2023-12-22 5:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 10,000 | $63.1 | 853,645 (Direct) | View |
2023-12-01 Option Award | 2023-12-12 7:55 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 2,370 | $0 | 672,645 (Direct) | View |
2023-10-04 Acquisition | 2023-12-12 7:55 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director | 10 | $85.57 | 672,645 (Direct) | View |
2023-12-01 Option Award | 2023-12-05 5:13 pm | 2024-12-01 2033-11-30 | BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer | 265,900 | $0 | 265,900 (Direct) | View |
2023-10-31 Option Award | 2023-12-05 4:59 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 133 | $69.23 | 52,014 (Direct) | View |
2023-12-01 Option Award | 2023-12-05 4:59 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 11,840 | $0 | 52,014 (Direct) | View |
2023-12-01 Option Award | 2023-12-05 4:56 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 17,750 | $0 | 194,254 (Direct) | View |
2023-04-28 Option Award | 2023-12-05 4:56 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 317 | $66.88 | 194,254 (Direct) | View |
2023-04-28 Option Award | 2023-08-17 3:57 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 318 | $66.88 | 60,804 (Direct) | View |